STOCK TITAN

[Form 4] EDGEWELL PERSONAL CARE Co Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Edgewell Personal Care insider filing shows executive departure and resulting equity changes. The Form 4 reports that Daniel Sullivan, the company's Chief Operating Officer, departed on October 1, 2025, triggering the disposition and forfeiture of equity awards. The filing records a disposition of 90,418 shares of common stock and notes that several unvested awards were forfeited upon departure. The form also lists multiple vested stock options and restricted stock equivalents that remained exercisable or convertible after departure, with holders typically having 90 days to exercise vested options. The filing is signed by an attorney-in-fact on October 2, 2025 and includes detailed counts and exercise prices for each option and award.

Edgewell Personal Care insider filing mostra la dipartita di un dirigente e i conseguenti cambiamenti nelle partecipazioni. Il modulo 4 riporta che Daniel Sullivan, il Chief Operating Officer dell'azienda, è uscito il 1 ottobre 2025, provocando la disposizione e la perdita di premi azionari. La documentazione registra una disposizione di 90.418 azioni ordinarie e nota che diversi premi non vestiti sono stati perduti al momento della dipartita. Il documento elenca anche numerose opzioni azionarie maturate e equivalenti di azioni vincolate che sono rimaste esercitabili o convertibili dopo la dipartita, con i detentori tipicamente che hanno 90 giorni per esercitare le opzioni maturate. La documentazione è firmata da un procuratore in forza il 2 ottobre 2025 e include conteggi dettagliati e prezzi di esercizio per ogni opzione e premio.

Edgewell Personal Care insider filing muestra la salida de un ejecutivo y los cambios de participación resultantes. El formulario 4 informa que Daniel Sullivan, el director de operaciones de la empresa, dejó la empresa el 1 de octubre de 2025, lo que provocó la disposición y la pérdida de premios en acciones. El informe registra una disposición de 90.418 acciones y señala que varios premios no adquiridos se perdieron al salir. El formulario también enumera varias opciones de acciones adquiridas y equivalentes de acciones restringidas que permanecieron ejercitables o convertibles después de la salida, y los tenedores normalmente tienen 90 días para ejercer las opciones adquiridas. El formulario está firmado por un apoderado el 2 de octubre de 2025 e incluye recuentos detallados y precios de ejercicio para cada opción y premio.

Edgewell Personal Care insider filing은 고위 경영진의 이직과 그에 따른 주식 지분 변화가 있음을 보여줍니다. Form 4는 회사의 COO인 Daniel Sullivan이 2025년 10월 1일에 퇴임했다고 보고하며, 이는 주식 보상 계약의 처분과 몰수를 촉발했습니다. 서류는 90,418주의 보통주 처분을 기록하고, 다수의 미 vest된 보상도 퇴임 시 몰수되었다고 명시합니다. 또한 양식은 퇴임 후에도 행사 가능하거나 전환 가능한 여러 행사된 주식 옵션과 제한 주식의 등가를 나열하며, 보유자는 일반적으로 90일 이내에 행사 가능한 옵션을 행사할 수 있습니다. 서류는 2025년 10월 2일에 대리인이 서명했고, 각 옵션과 보상에 대한 상세한 수와 행사가를 포함하고 있습니다.

Le dossier d'initiés Edgewell Personal Care montre le départ d'un dirigeant et les changements d'équité qui en découlent. Le formulaire 4 indique que Daniel Sullivan, le directeur des opérations de l'entreprise, est parti le 1er octobre 2025, déclenchant la disposition et la confiscation de récompenses en actions. Le dossier enregistre une désallocation de 90 418 actions et précise que plusieurs attributions non acquises ont été perdues au départ. Le formulaire répertorie également plusieurs options d'achat d'actions acquises et des équivalents d'actions restreintes qui sont restés exécutables ou convertibles après le départ, les détenteurs ayant généralement 90 jours pour exercer les options acquises. Le formulaire est signé par un mandataire le 2 octobre 2025 et comprend des dénombrements détaillés et des prix d'exercice pour chaque option et attribution.

Edgewell Personal Care Insider-Bericht zeigt den Abgang eines Executives und damit verbundene Veränderungen des Eigenkapitals. Das Formular 4 berichtet, dass Daniel Sullivan, der Chief Operating Officer des Unternehmens, am 1. Oktober 2025 ausgeschieden ist, was die Veräußerung und den Verzicht auf Aktienoptionen auslöste. Die Unterlage verzeichnet eine Veräußerung von 90.418 Aktien Stammaktien und notiert, dass mehrere nicht vestete Awards beim Ausscheiden verfallen sind. Das Formular listet auch mehrere vestete Aktienoptionen und Restricted-Stock-Äquivalente auf, die nach dem Ausscheiden weiterhin ausübbar oder konvertierbar blieben, wobei Inhaber in der Regel 90 Tage Zeit hatten, vestete Optionen auszuüben. Die Unterlage ist von einem Bevollmächtigten am 2. Oktober 2025 unterzeichnet und enthält detaillierte Zählungen und Ausübungspreise für jeden Option und Award.

تقرير داخلي لشركة Edgewell Personal Care يظهر مغادرة مدير تنفيذي وتغييرات في الملكية الناتجة. يبيّن النموذج 4 أن Daniel Sullivan، مدير العمليات بالشركة، غادر في 1 أكتوبر 2025، مما أدى إلى التصرف في الجوائز و- forfeiture-ها. يسجل التقرير تصرفاً في 90,418 سهماً عادياً ويشير إلى أن عدة جوائز لم تُكتسب بعد تم فقدها عند المغادرة. كما يورد النموذج العديد من خيارات الأسهم الممنوحة والمرادفات للأسهم المقيدة التي بقيت قابلة لممارسة أو التحويل بعد المغادرة، مع عادة أن يمتلك الحائزون 90 يوماً لممارسة الخيارات المُمنوحة. تم توقيع الملف من قبل محامٍ بالوكالة في 2 أكتوبر 2025 ويشمل عدّاً تفصيلياً وأسعار ممارسة لكل خيار وجائزة.

Edgewell Personal Care 内部交易申报显示高管离职及由此带来的股权变动。 Form 4 报告公司首席运营官 Daniel Sullivan 于 2025年10月1日离职,触发了股权奖励的处置和没收。该申报记录了 90,418股普通股的处置,并注明有若干未归属的奖励在离职时被没收。表格还列出多项已归属的股票期权以及受限股票等价物,在离职后仍可行使或转化,持有人通常有 90天 行使已归属的期权。该申报由代理律师于 2025年10月2日 签名,并包含每个期权及奖励的详细数量和行使价格。

Positive
  • Vested options retained: multiple vested option tranches remain exercisable within the standard 90-day post-departure window
  • Detailed disclosure: form provides explicit counts and exercise prices for each option and award enabling clear tracking
Negative
  • Disposition of 90,418 shares: reporting person sold or otherwise disposed of 90,418 shares of common stock
  • Forfeiture of unvested awards: multiple unvested awards were forfeited upon Mr. Sullivan's departure (counts listed in the filing)

Insights

TL;DR: Departure of a C-suite officer with immediate equity disposition and forfeitures.

The filing documents Daniel Sullivan's departure on October 1, 2025, and an associated sale/disposition of 90,418 shares of common stock. It also records the forfeiture of multiple unvested awards tied to his employment termination. For investors, the key governance signal is an executive exit that prompted automatic equity-accounting actions defined by the company’s award agreements.

TL;DR: Vested awards remain exercisable; numerous unvested awards were forfeited.

The Form 4 lists several vested stock-option tranches and restricted stock equivalents that remain exercisable or convertible and notes a standard 90-day exercise window following departure for vested options. The filing itemizes forfeited unvested awards (counts shown in the form) and lists vested option quantities and exercise prices that the reporting person can still exercise within the post-termination period.

Edgewell Personal Care insider filing mostra la dipartita di un dirigente e i conseguenti cambiamenti nelle partecipazioni. Il modulo 4 riporta che Daniel Sullivan, il Chief Operating Officer dell'azienda, è uscito il 1 ottobre 2025, provocando la disposizione e la perdita di premi azionari. La documentazione registra una disposizione di 90.418 azioni ordinarie e nota che diversi premi non vestiti sono stati perduti al momento della dipartita. Il documento elenca anche numerose opzioni azionarie maturate e equivalenti di azioni vincolate che sono rimaste esercitabili o convertibili dopo la dipartita, con i detentori tipicamente che hanno 90 giorni per esercitare le opzioni maturate. La documentazione è firmata da un procuratore in forza il 2 ottobre 2025 e include conteggi dettagliati e prezzi di esercizio per ogni opzione e premio.

Edgewell Personal Care insider filing muestra la salida de un ejecutivo y los cambios de participación resultantes. El formulario 4 informa que Daniel Sullivan, el director de operaciones de la empresa, dejó la empresa el 1 de octubre de 2025, lo que provocó la disposición y la pérdida de premios en acciones. El informe registra una disposición de 90.418 acciones y señala que varios premios no adquiridos se perdieron al salir. El formulario también enumera varias opciones de acciones adquiridas y equivalentes de acciones restringidas que permanecieron ejercitables o convertibles después de la salida, y los tenedores normalmente tienen 90 días para ejercer las opciones adquiridas. El formulario está firmado por un apoderado el 2 de octubre de 2025 e incluye recuentos detallados y precios de ejercicio para cada opción y premio.

Edgewell Personal Care insider filing은 고위 경영진의 이직과 그에 따른 주식 지분 변화가 있음을 보여줍니다. Form 4는 회사의 COO인 Daniel Sullivan이 2025년 10월 1일에 퇴임했다고 보고하며, 이는 주식 보상 계약의 처분과 몰수를 촉발했습니다. 서류는 90,418주의 보통주 처분을 기록하고, 다수의 미 vest된 보상도 퇴임 시 몰수되었다고 명시합니다. 또한 양식은 퇴임 후에도 행사 가능하거나 전환 가능한 여러 행사된 주식 옵션과 제한 주식의 등가를 나열하며, 보유자는 일반적으로 90일 이내에 행사 가능한 옵션을 행사할 수 있습니다. 서류는 2025년 10월 2일에 대리인이 서명했고, 각 옵션과 보상에 대한 상세한 수와 행사가를 포함하고 있습니다.

Le dossier d'initiés Edgewell Personal Care montre le départ d'un dirigeant et les changements d'équité qui en découlent. Le formulaire 4 indique que Daniel Sullivan, le directeur des opérations de l'entreprise, est parti le 1er octobre 2025, déclenchant la disposition et la confiscation de récompenses en actions. Le dossier enregistre une désallocation de 90 418 actions et précise que plusieurs attributions non acquises ont été perdues au départ. Le formulaire répertorie également plusieurs options d'achat d'actions acquises et des équivalents d'actions restreintes qui sont restés exécutables ou convertibles après le départ, les détenteurs ayant généralement 90 jours pour exercer les options acquises. Le formulaire est signé par un mandataire le 2 octobre 2025 et comprend des dénombrements détaillés et des prix d'exercice pour chaque option et attribution.

Edgewell Personal Care Insider-Bericht zeigt den Abgang eines Executives und damit verbundene Veränderungen des Eigenkapitals. Das Formular 4 berichtet, dass Daniel Sullivan, der Chief Operating Officer des Unternehmens, am 1. Oktober 2025 ausgeschieden ist, was die Veräußerung und den Verzicht auf Aktienoptionen auslöste. Die Unterlage verzeichnet eine Veräußerung von 90.418 Aktien Stammaktien und notiert, dass mehrere nicht vestete Awards beim Ausscheiden verfallen sind. Das Formular listet auch mehrere vestete Aktienoptionen und Restricted-Stock-Äquivalente auf, die nach dem Ausscheiden weiterhin ausübbar oder konvertierbar blieben, wobei Inhaber in der Regel 90 Tage Zeit hatten, vestete Optionen auszuüben. Die Unterlage ist von einem Bevollmächtigten am 2. Oktober 2025 unterzeichnet und enthält detaillierte Zählungen und Ausübungspreise für jeden Option und Award.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Sullivan Daniel

(Last) (First) (Middle)
C/O EDGEWELL PERSONAL CARE COMPANY
6 RESEARCH DRIVE

(Street)
SHELTON CT 06484

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co [ EPC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 90,418 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Options 11-11-2022 $39.75 10/01/2025 J V 6,132(1) 11/11/2023 11/11/2032 Common Stock 6,132 $0 12,265(2) D
Non-Qualified Stock Options 11/12/2021 $43.29 10/01/2025 J V 0 11/12/2022 11/12/2031 Common Stock 0 $0 16,428(3) D
Non-Qualified Stock Options 11/13/2020 $35.37 10/01/2025 J V 0 11/13/2021 11/13/2030 Common Stock 0 $0 8,857(3) D
Non-Qualified Premium Stock Options 11/13/2020 $38.91 10/01/2025 J V 0 11/13/2021 11/13/2030 Common Stock 0 $0 18,535(3) D
Non-Qualified Stock Options 11/14/2019 $31.44 10/01/2025 J V 0 11/14/2020 11/14/2029 Common Stock 0 $0 23,580(3) D
Non-Qualified Stock Options 11/10/2023 $34.22 10/01/2025 J V 13,848(1) 11/10/2024 11/10/2033 Common Stock 13,848 $0 6,924(2) D
Restricted Stock Equivalent 11/11/2022 $0 10/01/2025 J V 3,522(1) 11/11/2023 11/11/2025 Common Stock 3,522 $0 0 D
Restricted Stock Equivalent 11/10/2023 $0 10/01/2025 J V 8,182(1) 11/10/2024 11/10/2026 Common Stock 8,182 $0 0 D
Restricted Stock Equivalent 11/8/2024 $0 10/01/2025 J V 17,700(1) 11/08/2025 11/08/2027 Common Stock 17,700 $0 0 D
Performance Restricted Stock Equivalent 11/11/2022 $0 10/01/2025 J V 35,221(1) 11/11/2025 11/11/2025 Common Stock 35,221 $0 0 D
Performance Restricted Stock Equivalent 11/10/2023 $0 10/01/2025 J V 40,912(1) 11/10/2026 11/10/2026 Common Stock 40,912 $0 0 D
Performance Restricted Stock Equivalent 11/8/2024 $0 10/01/2025 J V 53,098(1) 11/11/2027 11/11/2027 Common Stock 53,098 $0 0 D
Explanation of Responses:
1. Unvested award forfeited upon Mr. Sullivan's departure from the Company on October 1, 2025.
2. These options were vested prior to Mr. Sullivan's departure from the Company. He has 90 days from his departure date to exercise them.
3. There were no unvested options for this award to forfeit at the time of Mr. Sullivan's departure from the Company. This is the number of vested and exercisable options that he has 90 days to exercise from the date of his departure.
/s/ LaTanya Langley, Attorney-in-Fact 10/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Daniel Sullivan report on the Form 4 for EPC?

The Form 4 reports Mr. Sullivan's departure on October 1, 2025, a disposition of 90,418 shares, and the forfeiture of several unvested equity awards.

Does Mr. Sullivan keep any equity after leaving EPC (EPC)?

Yes. The filing lists multiple vested stock options and restricted stock equivalents that remain exercisable or convertible; vested options generally have a 90-day exercise window from the departure date.

Which unvested awards were forfeited upon departure?

The filing's Explanation notes that unvested awards identified with footnote (1) were forfeited upon Mr. Sullivan's departure; the form lists those awards and their share counts.

What is the exercise period for vested options after Mr. Sullivan’s departure?

The Form 4 states vested options were exercisable and that Mr. Sullivan has 90 days from his departure date to exercise them.

When was the Form 4 signed and filed?

The Form 4 is signed by LaTanya Langley, Attorney-in-Fact, on October 2, 2025.
Edgewell Pers Care Co

NYSE:EPC

EPC Rankings

EPC Latest News

EPC Latest SEC Filings

EPC Stock Data

940.90M
45.27M
2.57%
105.75%
5.29%
Household & Personal Products
Perfumes, Cosmetics & Other Toilet Preparations
Link
United States
SHELTON